PROCESSA PHARMACEUTICALS ANNOUNCES THAT IT HAS ENTERED INTO AN AGREEMENT WITH APOSENSE, LTD TO LICENSE IN THE NEXT GENERATION IRINOTECAN DRUG
Stock Information for Processa Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.